UBS Plans to Complete Credit Suisse Takeover as Early as June 12

UBS Group AG expects to complete its acquisition of Credit Suisse Group AG as early as June 12,

2023-06-05 13:24

Walmart Lifts Profit Outlook, Stays Cautious on US Consumers

Walmart Inc. modestly raised its annual profit forecast but struck a cautious tone about the outlook for US

2023-11-16 20:15

Inside Covid czar Anthony Fauci and wife's $2M pandemic windfall

According to reports, Dr Anthony Fauci earned about $480,000 per year, which is more than President Joe Biden's yearly salary of $400,000

2023-09-20 04:30

Corent’s SaaSOps™ powers Everything Blockchain’s next-gen “Database as a Service” on AWS Cloud and AWS Cloud Marketplace

ALISO VIEJO, Calif., & JACKSONVILLE, Fla.--(BUSINESS WIRE)--Aug 28, 2023--

2023-08-28 18:29

Egypt Currency Squeeze Sinks Bank Foreign Buffers to New Low

Net foreign assets held by Egypt’s commercial banks went into a record deficit in June, as a lack

2023-08-02 16:49

G-7 Latest: Zelenskiy to Visit Japan, Leaders Tour A-Bomb Museum

Ukrainian President Volodymyr Zelenskiy is set to visit Group of Seven leaders in Japan for one of his

2023-05-19 13:45

Bank of America CEO sees investment banking and trading staying flat in Q2

NEW YORK Bank of America Corp expects investment banking fees and trading revenues to be broadly flat this

2023-06-02 03:23

Kiboko Drills 4.2 g/t Au Over 5 m at its Harricana Gold Project

KELOWNA, British Columbia--(BUSINESS WIRE)--Jul 10, 2023--

2023-07-11 04:16

US consumer watchdog proposes rules for Big Tech payments, digital wallets

WASHINGTON The top U.S. consumer financial watchdog on Tuesday proposed to regulate tech giants' digital payments and smartphone

2023-11-08 01:27

Markets sink, dollar gains as Fed hints at fresh rate hike

Asian and European stocks sank Thursday and the dollar advanced after the US Federal Reserve indicated it could hike interest rates again this year and keep them elevated longer than feared as...

2023-09-21 16:54

FDA Weighing What to Do About $900,000 Drug That May Not Work

The cancer drug Folotyn, one of the most expensive in the US, received a short-cut approval from US

2023-11-16 18:52

Beijing’s Market-Support Pledges Falling Flat With Traders

China’s top-down vow to rejuvenate markets hasn’t resonated with investors, as initial excitement evaporates in a mire of

2023-09-21 11:25